What Alfasan does

Alfasan Diergeneesmiddelen B.V. is a privately held Dutch veterinary pharmaceutical manufacturer founded in 1975 and headquartered in Woerden, The Netherlands. The company specializes in producing injectable solutions and suspensions for veterinary applications, with a portfolio of 1,900+ registered products spanning 150+ distinct formulations across therapeutic groups including injectable solutions, suspensions, intramammary injectors, eye medications, tablets, and powders. A key technical feature is the dual production facility design, with completely isolated units for penicillin and non-penicillin injection fluids, each with independent climate control, enabling simultaneous manufacture without cross-contamination risk. The manufacturing process is fully automated and configured for 2,000L batches under strict GMP and GDP regulations.

The company operates as a manufacturer-distributor selling directly to veterinarians, farm animal owners, and through authorized distribution partners across 110 countries. In 2016, Alfasan extended into natural preventive products through a Green Division aimed at reducing antibiotic reliance. Distribution is multi-channel, combining international distributors, direct sales via a Quality Control department, and reporting channels to national competent authorities. Alfasan maintains a formal pharmacovigilance system with 24/7 Qualified Person for PharmacoVigilance (QPPV) availability.

Alfasan is currently executing a renewal and expansion program (announced 2023) that includes construction of a new office, machinery expansion, new product introductions, and a new corporate identity with updated product logos. The company has 51-100 employees, is privately held with no identified external parent or investor, and operates under the Alfasan Group of Companies umbrella. Ownership is associated with co-owner Alexander Tesink as founder. No AI/ML capabilities, software products, or digital platforms are part of the offering; the competitive position is built on regulatory certifications, manufacturing infrastructure, and product breadth.

Name

Alfasan

Legal name

Alfasan Diergeneesmiddelen B.V.

Website

https://alfasan.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

51–100 employees

Short description

Alfasan is a Dutch veterinary pharmaceutical manufacturer founded in 1975, producing injectable solutions, suspensions, and other formulations under GMP/GDP certification for veterinarians and farm animal owners across 110 countries.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals) (HLAMAEAN)

akta.pro secondary industries

Antimicrobials & Anti-infectives (HLAMAEAE), Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)

Keywords

• Veterinary pharmaceuticals
• Animal medicines manufacturing
• Injectable veterinary solutions
• Intramammary veterinary products
• GMP certified veterinary drugs

Headquarters

HQ city

Woerden

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Veterinary Medicines Sales: Alfasan manufactures and distributes a wide range of veterinary medicines including injectable solutions, suspensions, intramammary injectors, eye medication, tablets, and powders across therapeutic groups. Products are sold in 110 countries through multiple distribution channels.
2. Natural Products Division: Green division established in 2016 offering natural products for animal disease prevention, contributing to reduced antibiotic use.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Alfasan manufactures and distributes a portfolio of veterinary medicines including injectable solutions, injectable suspensions, intramammary injectors, eye medication, tablets, and powders across multiple therapeutic groups. The company operates a GMP- and GDP-certified facility in Woerden, the Netherlands, with two completely isolated production units for penicillin and non-penicillin products configured for 2000L batches. In 2016, it also established a Green Division focused on natural preventive products to reduce antibiotic use.

Product overview

Alfasan is a manufacturer of veterinary medicines operating since 1975 from Woerden, The Netherlands. The company produces a portfolio of over 150 different products including injectable solutions, injectable suspensions (with separate production units for penicillin and non-penicillin fluids), intramammary injectors, eye medication, tablets, and powders across various therapeutic groups. In 2016, Alfasan established a Green Division focused on natural products for disease prevention to reduce antibiotic use. All products are manufactured under strict GMP conditions and are available in 110 countries with over 1900 registered veterinary medicines.

Differentiator

Problem solved

Functional benefit

Products and services

• Injectable Solutions Veterinary injectable solutions manufactured in Alfasan's GMP-certified facility, used by veterinarians and animal owners for treating diseases in livestock and companion animals.
• Injectable Suspensions Veterinary injectable suspensions, including both penicillin and non-penicillin formulations, manufactured in completely separate isolated production units with independent climate control to prevent cross-contamination.
• Intramammary Injectors Veterinary intramammary injector products offered across a wide range of therapeutic groups for the treatment of mastitis and related conditions in dairy animals.
• Eye Medication Veterinary ophthalmic medications offered within Alfasan's therapeutic product range for the treatment of eye conditions in animals.
• Veterinary Tablets Oral veterinary tablet medications offered across a wide range of therapeutic groups for the treatment of animal diseases.
• Veterinary Powders Veterinary powder medications offered across a wide range of therapeutic groups, typically administered via feed or water for livestock and other animals.
• Natural Products (Green Division) A separate product line launched in 2016 offering natural preventive products for animal disease prevention, designed to help reduce reliance on antibiotics in livestock and farming operations.

Quantifiable outcome

• 1900+ registered veterinary medicines across 110 countries
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hipra: Spanish veterinary biologics and pharmaceutical company with strong focus on livestock vaccines and pharmaceuticals; comparable European mid-sized specialist manufacturer.
• Vetoquinol: Independent French veterinary pharmaceutical company specializing in vet medicines across multiple therapeutic areas, with similar mid-sized manufacturer-distributor profile and global presence.
• Phibro Animal Health: US-based animal health and nutrition company producing veterinary pharmaceuticals, vaccines, and feed additives; comparable diversified portfolio serving livestock and companion animals globally.
• Ceva Santé Animale: French veterinary pharmaceutical company offering vaccines, pharmaceuticals, and biological products across multiple species with global distribution — strong overlap with Alfasan's portfolio and footprint.
• Dechra Pharmaceuticals: UK-headquartered veterinary pharmaceutical company specializing in companion animal and livestock medicines; comparable mid-market specialty manufacturer with global reach.
• Virbac: French veterinary pharmaceutical company focused exclusively on animal health, offering vaccines, antibiotics, and specialty products globally — directly comparable in product breadth and international distribution model.

Broad incumbents

• Zoetis: Largest pure-play animal health company globally, offering pharmaceuticals, vaccines, diagnostics, and medicated feed additives; operates across the same therapeutic categories as Alfasan at much greater scale.
• MSD Animal Health: Animal health division of Merck offering a broad portfolio of veterinary pharmaceuticals, vaccines, and parasiticides; competes in the same therapeutic areas as Alfasan with much larger R&D and commercial resources.
• Boehringer Ingelheim Animal Health: Major animal health player offering vaccines, therapeutics, and pharmaceuticals across livestock and companion animal segments; overlaps heavily with Alfasan's product portfolio across global markets.

Regional players

• Bioveta: Czech veterinary pharmaceutical and vaccine manufacturer with a broad portfolio of veterinary medicines and biologics — similar product mix, primarily serving Central and Eastern European markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alfasan